1
|
Pizzighello S, Uliana M, Martinuzzi M, Vascello MGF, Cipriani M, Breda M, De Polo G, Martinuzzi A. The perceived impact of Covid-19 pandemic on the children with cerebral palsy: the parents' perspective explored within the "6-F words" framework. Child Adolesc Psychiatry Ment Health 2023; 17:24. [PMID: 36793119 PMCID: PMC9930050 DOI: 10.1186/s13034-023-00569-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2022] [Accepted: 01/31/2023] [Indexed: 02/17/2023] Open
Abstract
BACKGROUND In 2020 the world faced the spread of the coronavirus infection disease (Covid-19). This was a general public health emergency but many people with disabilities might have been particularly affected. OBJECTIVE This paper aims to investigate the impact of the Covid-19 pandemic on children with Cerebral Palsy (CP) and their families. METHODS 110 parents of children with CP (aged 2 to 19) who completed a questionnaire were included. These children were under the care of one of the Italian Children Rehabilitation Centers. Socio-demographic and clinical information about patients and their families were collected. In addition, difficulties on adopting protective measures and in respecting lockdown rules by children were explored. We adopted the ICF (International Classification of Functioning, Disability and Health) framework to create multiple choice questions. Descriptive statistics were reported and logistic regression analyses were run in order to identify the predictors of perceived impairment in motor, speech, manual and behavioral abilities. RESULTS Daily activities of children, as well as rehabilitation and fitness sessions, underwent a change during the pandemic. Spending more time with family due to lockdown measures, has had, in some cases a positive effect however there was a perceived decrease in rehabilitation support and school activities. The age range (between 7 and 12 years) and difficulty in respecting rules emerged as significant predictors of the perceived impairment due to Covid-19 pandemic. CONCLUSIONS The pandemic has had different impacts on children and their families on the basis of children's characteristics. Rehabilitation activities during a hypothetic lockdown should consider these characteristics.
Collapse
Affiliation(s)
- Silvia Pizzighello
- Department of Conegliano, Scientific Institute IRCCS E. Medea, Via Costa Alta, 37, 31015, Conegliano, Treviso, Italy.
| | - Marianna Uliana
- grid.420417.40000 0004 1757 9792Department of Conegliano, Scientific Institute IRCCS E. Medea, Via Costa Alta, 37, 31015 Conegliano, Treviso Italy
| | - Michela Martinuzzi
- grid.13097.3c0000 0001 2322 6764King’s College London GKT School of Medical Education, London, UK
| | - Matteo G. F. Vascello
- grid.460094.f0000 0004 1757 8431Clinical Psychology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy
| | - Martina Cipriani
- grid.420417.40000 0004 1757 9792Department of Conegliano, Scientific Institute IRCCS E. Medea, Via Costa Alta, 37, 31015 Conegliano, Treviso Italy
| | - Martina Breda
- grid.420417.40000 0004 1757 9792Department of Conegliano, Scientific Institute IRCCS E. Medea, Via Costa Alta, 37, 31015 Conegliano, Treviso Italy
| | - Gianni De Polo
- grid.420417.40000 0004 1757 9792Department of Conegliano, Scientific Institute IRCCS E. Medea, Via Costa Alta, 37, 31015 Conegliano, Treviso Italy
| | - Andrea Martinuzzi
- grid.420417.40000 0004 1757 9792Department of Conegliano, Scientific Institute IRCCS E. Medea, Via Costa Alta, 37, 31015 Conegliano, Treviso Italy
| |
Collapse
|
2
|
Mazumder R, Lagoro DK, Nariai H, Danieli A, Eliashiv D, Engel J, Dalla Bernardina B, Kegele J, Lerche H, Sejvar J, Matuja W, Schmutzhard E, Bonanni P, De Polo G, Wagner T, Winkler AS. Ictal Electroencephalographic Characteristics of Nodding Syndrome: A Comparative Case-Series from South Sudan, Tanzania, and Uganda. Ann Neurol 2022; 92:75-80. [PMID: 35438201 PMCID: PMC9544008 DOI: 10.1002/ana.26377] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Revised: 04/14/2022] [Accepted: 04/15/2022] [Indexed: 11/30/2022]
Abstract
Nodding syndrome (NS) is a poorly understood form of childhood‐onset epilepsy that is characterized by the pathognomonic ictal phenomenon of repetitive vertical head drops. To evaluate the underlying ictal neurophysiology, ictal EEG features were evaluated in nine participants with confirmed NS from South Sudan, Tanzania, and Uganda and ictal presence of high frequency gamma oscillations on scalp EEG were assessed. Ictal EEG during the head nodding episode predominantly showed generalized slow waves or sharp‐and‐slow wave complexes followed by electrodecrement. Augmentation of gamma activity (30–70 Hz) was seen during the head nodding episode in all the participants. We confirm that head nodding episodes in persons with NS from the three geographically distinct regions in sub‐Saharan Africa share the common features of slow waves with electrodecrement and superimposed gamma activity. ANN NEUROL 2022;92:75–80
Collapse
Affiliation(s)
- Rajarshi Mazumder
- David Geffen School of Medicine, Department of Neurology, University of California, Los Angeles, CA
| | | | - Hiroki Nariai
- Division of Pediatric Neurology, Department of Pediatrics, UCLA Mattel Children's Hospital, David Geffen School of Medicine, University of California, Los Angeles, CA
| | - Alberto Danieli
- Epilepsy and Clinical Neurophysiology Unit, Scientific Institute IRCCS E. Medea, Conegliano (TV), Italy
| | - Dawn Eliashiv
- David Geffen School of Medicine, Department of Neurology, University of California, Los Angeles, CA
| | - Jerome Engel
- David Geffen School of Medicine, Department of Neurology, University of California, Los Angeles, CA
| | - Bernardo Dalla Bernardina
- Child Neuropsychiatry, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.,Research Center for Pediatric Epilepsies Verona, Verona, Italy
| | - Josua Kegele
- Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
| | - Holger Lerche
- Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
| | - James Sejvar
- Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA
| | - William Matuja
- Department of Neurology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
| | - Erich Schmutzhard
- Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
| | - Paolo Bonanni
- Epilepsy and Clinical Neurophysiology Unit, Scientific Institute IRCCS E. Medea, Conegliano (TV), Italy
| | - Gianni De Polo
- Scientific Institute IRCCS E. Medea, Conegliano (TV), Italy
| | - Thomas Wagner
- Center for Childhood and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany
| | - Andrea Sylvia Winkler
- Department of Neurology, Center for Global Health, School of Medicine, Technical University of Munich, Munich, Germany.,Centre for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway
| |
Collapse
|
3
|
Affiliation(s)
- Andrea Martinuzzi
- “E. Medea-La Nostra Famiglia” Institute, Conegliano Research Centre, Conegliano, Italy
| | - Gianni De Polo
- “E. Medea-La Nostra Famiglia” Institute, Conegliano Research Centre, Conegliano, Italy
| | - Sonia Bortolot
- “E. Medea-La Nostra Famiglia” Institute, Conegliano Research Centre, Conegliano, Italy
| | - Monica Pradal
- “E. Medea-La Nostra Famiglia” Institute, Conegliano Research Centre, Conegliano, Italy
| |
Collapse
|
4
|
De Polo G, Pradal M, Bortolot S, Buffoni M, Martinuzzi A. Children with disability at school: the application of ICF-CY in the Veneto region. Disabil Rehabil 2009; 31 Suppl 1:S67-73. [DOI: 10.3109/09638280903317880] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
5
|
Zucca C, Redaelli F, Epifanio R, Zanotta N, Romeo A, Lodi M, Veggiotti P, Airoldi G, Panzeri C, Romaniello R, De Polo G, Bonanni P, Cardinali S, Baschirotto C, Martorell L, Borgatti R, Bresolin N, Bassi MT. Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified. ACTA ACUST UNITED AC 2008; 65:489-94. [PMID: 18413471 DOI: 10.1001/archneur.65.4.489] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
BACKGROUND Sodium channel alpha 1 subunit gene, SCN1A, is the gene encoding the neuronal voltage-gated sodium channel alpha 1 subunit (Na(v)1.1) and is mutated in different forms of epilepsy. Mutations in this gene were observed in more than 70% of patients with severe myoclonic epilepsy of infancy (SMEI) and were also found in different types of infantile epileptic encephalopathy. OBJECTIVE To search for disease-causing mutations in SCN1A in patients with cryptogenic epileptic syndromes (ie, syndromes with an unknown cause). DESIGN Clinical characterization and molecular genetic analysis of a cohort of patients. SETTING University hospitals, rehabilitation centers, and molecular biology laboratories. PATIENTS Sixty unrelated patients with cryptogenic epileptic syndromes. MAIN OUTCOME MEASURES Samples of DNA were analyzed for mutations and for large heterozygous deletions encompassing the SCN1A gene. A search for microdeletions in the SCN1A gene was also performed in the subset of patients with SMEI/SMEI-borderland who had negative results at the point mutation screening. RESULTS No large deletions at the SCN1A locus were found in any of the patients analyzed. In contrast, 13 different point mutations were identified in 12 patients: 10 with SMEI, 1 with generalized epilepsy with febrile seizures plus, and 1 with cryptogenic focal epilepsy. An additional search for SCN1A intragenic microdeletions in the remaining patients with SMEI/SMEI-borderland and no point mutations was also negative. CONCLUSIONS These results confirm the role of the SCN1A gene in different types of epilepsy, including cryptogenic epileptic syndromes. However, large deletions encompassing SCN1A were not common disease-causing rearrangements in this group of epilepsies.
Collapse
Affiliation(s)
- Claudio Zucca
- Clinical Neurophysiology Unit, E. Medea Scientific Institute, Lecco, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Panzeri C, De Palma C, Martinuzzi A, Daga A, De Polo G, Bresolin N, Miller CC, Tudor EL, Clementi E, Bassi MT. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain 2006; 129:1710-9. [PMID: 16670179 DOI: 10.1093/brain/awl104] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Primary lateral sclerosis (PLS) is a rare progressive paralytic disorder that results from dysfunction of the upper motoneurons. Although PLS is a sporadic disorder of adult middle age, it has also been described in children as juvenile PLS or JPLS. The causative gene for JPLS was found to be ALS2, which is also responsible for a recessive form of amyotrophic lateral sclerosis, for infantile onset ascending hereditary spastic paralysis (IAHSP) and for a form of complicated hereditary spastic paraplegia (cHSP). ALS2 gene encodes a protein termed alsin, containing multiple guanine nucleotide exchange factor domains, specifically binding to small GTPase Rab5 and acting as a GEF for Rab5. In vitrostudies performed with full-length and truncating forms of alsin protein support its role in endosomal dynamics and trafficking of mitochondria. All ALS2 mutations so far reported generate alsin protein truncation. Here, we describe the first homozygous missense mutation in ALS2, p.G540E. The mutation, which falls within the RCC1 domain, was identified in a 34-year-old patient with typical signs of JPLS such as ascending generalized and severe spasticity involving the limbs and the bulbar region, dysphagia, limb atrophy, preserved cognition and sensation. The father and two proband's sisters were found to be heterozygous carriers of the mutation with no signs of the disease. Studies in the neuronal cell line SK-N-BE indicated that the known subcellular localization of wild-type alsin with the early endosome antigen 1, in enlarged endosomal structures, and transferrin receptor is completely lost by the mutant protein, thus indicating that this mutation leads to protein delocalization. Mutant alsin induced neuronal death itself and also significantly enhanced the apoptogenic effect of NMDA and staurosporine. This effect was associated with decreased Bcl-xL : Bax ratio. In contrast, wild-type alsin was neuroprotective and increased Bcl-xL : Bax ratio. Our results provide the first demonstration that a missense mutation in alsin is cytotoxic. In addition, the identification of Bcl-xL/Bax as target of protection by alsin and of cytotoxicity by the mutant form provides a new signalling event regulated by alsin protein that may be important to define its role in neuronal physiology and neurodegeneration. Finally, the phenotype-genotype correlation in our patient, in view of all other ALS2 mutant cases reported previously, suggests a functional interplay of long and short forms of alsin in relation to disease onset and progression.
Collapse
Affiliation(s)
- Chris Panzeri
- IRCCS E. Medea, Laboratory of Molecular Biology, Bosisio Parini Lecco, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|